Page last updated: 2024-08-25

9-aminocamptothecin and Cancer of Skin

9-aminocamptothecin has been researched along with Cancer of Skin in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Daoud, SS; Fetouh, MI; Giovanella, BC1
Arbuck, S; Argiris, A; Cooper, DL; DiStasio, S; Foss, FM; Heald, P; Kuzel, T; Murren, JR1

Trials

1 trial(s) available for 9-aminocamptothecin and Cancer of Skin

ArticleYear
Phase II trial of 9-aminocamptothecin as a 72-h infusion in cutaneous T-cell lymphoma.
    Investigational new drugs, 2001, Volume: 19, Issue:4

    Topics: Adult; Antineoplastic Agents; Camptothecin; Disease Progression; Female; Granulocyte Colony-Stimulating Factor; Humans; Infusions, Intravenous; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged; Neutropenia; Skin Neoplasms; Time Factors; Treatment Outcome

2001

Other Studies

1 other study(ies) available for 9-aminocamptothecin and Cancer of Skin

ArticleYear
Antitumor effect of liposome-incorporated camptothecin in human malignant xenografts.
    Anti-cancer drugs, 1995, Volume: 6, Issue:1

    Topics: 1,2-Dipalmitoylphosphatidylcholine; Animals; Breast Neoplasms; Camptothecin; Carcinoma; Cholesterol; Drug Carriers; Drug Evaluation, Preclinical; Humans; Liposomes; Melanoma, Experimental; Mice; Mice, Nude; Molecular Structure; Neoplasm Proteins; Neoplasm Transplantation; Phosphatidylinositols; Remission Induction; Skin Neoplasms; Sphingomyelins; Topoisomerase I Inhibitors

1995